Showing results (1421-1430 of 3,083) with videos related to

Sort By:
Pageof 309
Drug Safety|July 15, 2019
Multimodal Analysis of FDA Drug Safety Communications: Lessons from ZolpidemAaron S Kesselheim, Michael S Sinha, Eric G Campbell, et al.
Drug Safety|July 15, 2019
Patient Registries: An Underused Resource for Medicines Evaluation : Operational proposals for increasing the use of patient registries in regulatory assessmentsPatricia McGettigan, Carla Alonso Olmo, Kelly Plueschke, et al.
Drug Safety|November 14, 2016
Proton Pump Inhibitors and Risk of RhabdomyolysisScott J Duncan, Colin W Howden
Drug Safety|February 28, 2008
The US FDA 'black box' warning for topical calcineurin inhibitors: an ongoing controversyJohannes Ring, Matthias Möhrenschlager, Verena Henkel
Drug Safety|February 28, 2008
Drug-induced taste disordersRichard L Doty, Muhammad Shah, Steven M Bromley
Drug Safety|January 10, 2014
Antipsychotic drug exposure and risk of venous thromboembolism: a systematic review and meta-analysis of observational studiesCorrado Barbui, Valentino Conti, Andrea Cipriani
Drug Safety|November 10, 2012
Current challenges and controversies in drug-induced liver injuryAlberto Corsini, Patricia Ganey, Cynthia Ju, et al.
Drug Safety|January 22, 2014
Signal detection of potentially drug-induced acute liver injury in children using a multi-country healthcare database networkCarmen Ferrajolo, Preciosa M Coloma, Katia M C Verhamme, et al.
Drug Safety|June 28, 2014
Indicators of drug-seeking aberrant behaviours: the feasibility of use in observational post-marketing cohort studies for risk managementDeborah Layton, Vicki Osborne, Mohammad Al-Shukri, et al.
Drug Safety|May 30, 2014
Association between use of multiple psychoactive medicines and hospitalization for falls: retrospective analysis of a large healthcare claim databaseNicole L Pratt, Emmae N Ramsay, Lisa M Kalisch Ellett, et al.
Pageof 309